The demand for coronary stents in USA is projected to grow from USD 13.3 billion in 2025 to USD 22.3 billion by 2035, at a CAGR of 5.3%. Drug Eluting Stent (DES) will dominate with a 33.2% market share, while cobalt-chromium will lead the raw material segment with a 35.0% share.